Recombinant Full-Length H1N1 A/Solomon Islands/03/2006 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells.
Formulation: The Recombinant H1N1 A/Solomon Islands/03/2006 solution contains 10mM Sodium phosphate, pH 7.1,150mM NaCl and 0.005% Tween-20.
Physical Appearance: Sterile Filtered colorless solution.
Purity: Greater than 90% as determined by SDS-PAGE.
Source: Baculovirus Insect Cells.
Stability: H1N1 A/Solomon Islands/03/2006 Recombinant should be stored at +4°C.
Transportation method: Shipped with Ice Packs.
References: 1.Title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionPublication: The Rockefeller University Press, doi: 10.1084/jem.20101352 © 2011 Wrammert et al. Link:http://jem.rupress.org/content/early/2011/01/06/jem.20101352.full2.Title:Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.Publication:The Journal of Clinical Investigation http://www.jci.org Volume 120 Number 5 May 2010.Link:http://www.jci.org/articles/view/41902/files/pdf
Safety data sheet: Inquire at
info@3hbiomedical.com